Pfizer Suspends Celebrex Advertising

"Pfizer Inc. is indefinitely suspending all consumer advertising of its arthritis drug Celebrex, following last week's revelation of a study that showed high doses caused an increased risk of heart attacks among cancer patients." [Atlanta Journal-Constitution]